Session Details
[D1-A4]Strategic activities of EBF towards the Future of Bioanalysis
Wed. Mar 4, 2026 5:50 PM - 6:40 PM JST
Wed. Mar 4, 2026 8:50 AM - 9:40 AM UTC
Wed. Mar 4, 2026 8:50 AM - 9:40 AM UTC
Medium Hall(2nd Floor)
Chairman:Takashi Miyayama(Chugai Pharmaceutical Co., Ltd.), Makoto Takahashi(Daiichi Sankyo Co., Ltd.)
[D1-A4-01]From Compliance to Consequence: Context-of-Use as the Foundation for the Next Phase of Bioanalytical Science
*Philip Timmerman1 (1. European Bioanalysis Forum (EBF))
[D1-A4-02]Rethinking Replicates: Singlicate Analysis as a Data-Driven Step Toward the Future of Bioanalysis
*Matthew Barfield1 (1. On behalf of the European Bioanalysis Forum (EBF))